Aerius 5mg Organon reduces allergic rhinitis, urticaria (1 blister x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 1 blister x 10 tablets
Ingredient Desloratadine

Ingredient

Composition informationContent
Desloratadine5mg

Uses

indications

Aerius is indicated in the following cases:

  • Aerius is indicated to quickly reduce the symptoms related to allergic rhinitis, such as sneezing, runny nose and itchy nose, congestion/stuffy nose, as well as itching, tearing and redness, itchy throat and cough. Learning

    After drinking, desloratadine selectively inhibits the peripheral H1 histamine receptor because the drug is completely absorbed into the central nervous system (CNS).

    Determined the safety of Aerius Sirus in three clinical trials in children. Children from 6 months to 11 years old are treated for daily hypamine resistance 1 mg (6 to 11 months), 1.25 mg (1 to 5 years old) or 2.5 mg (6 to 11 years old). Treatment is well tolerated as recorded by subclinical tests, signs of survival, and electrocardiogram (ECG), including QTC. When using the dose recommends the same plasma desloratadine concentration between children and adults. Due to the similar results between adult patients and children in the study of seasonal allergic rhinitis/chronic urticaria (Seasonal Alermic Rhinitis/Chronic Idiopathic Urticaria - SAR/CIU), it is possible to external data on the efficiency of desloratadine in adults for children.

    In a multi -dose clinical study, Desloratadine uses up to 20 mg/day for 14 days, not observing the impact on the heart is clinically or statistical significance. In a clinical pharmacological trial using desloratadine at a dose of 45 mg/day (9 times higher than the clinical dose) for 10 days, no QTC distance is not seen.

    Desloratadine does not seep into the central nervous system. With a dose of 5 mg/day, the drowsiness rate is not higher than the placebo. In clinical trials using Aerius tablets at a dose of 7.5 mg/day, there is no impact on mental activity. In a single -dose study, Desloratadine 5 mg does not affect the standard assessment of flight performance including drowsiness or flight -related tasks.

    Do not observe clinical changes related to plasma desloratadine concentrations in multi -dose interactive tests with ketoconazole, erythromycin, azithromycin, fluoxetine and cimetidine.

    In clinical pharmacological tests, used at the same time with alcohol does not increase cognitive decline due to alcohol or increased drowsiness. There is no significant difference in mental mental test results between the group using desloratadine and Placeboo, whether used alone or with alcohol.

    In patients with allergic rhinitis (AR), Aerius tablets have the effect of reducing symptoms such as sneezing, runny nose and itchy nose, congestion/stuffy nose, as well as itchy eyes, tearing and redness, itching throat. Aerius tablets control symptoms effectively within 24 hours.

    Supplemented for the existing classification of seasonal and year -round allergic rhinitis, which can classify allergic rhinitis in another way such as interrupted allergic rhinitis and prolonged allergic rhinitis depending on the time of symptoms. Interrupted allergic rhinitis is determined when symptoms appear 4 weeks.

    In two 4 -week trials in seasonal allergic rhinitis patients with asthma, desloratadine is effective in reducing the symptoms of seasonal and asthma allergic rhinitis, and reducing the use of beta inhibitors, does not adversely affect the maximum exhaled gas volume in a second (FEV1). Improving symptoms without reducing the lung function has strengthened the safety of the use of desloratadine for patients with seasonal allergic rhinitis with mild and medium asthma.

    Due to the same pathophysiology, regardless of the cause and because chronic patients can be more selected, chronic spontaneous urticaria has been studied as a clinical trial for urticaria. The release of histamine is the cause of all urticaria, so the desloratadine is said to be effective reducing symptoms for urticarias besides chronic horned urticaria, as recommended in clinical instructions.

    In experiments in adults and young people with spontaneous urticaria (CIU), Aerius tablet effectively reduces itching and reduces the size, the number of rash 1 day after the beginning of treatment. In each clinical trial, this effect maintains 24 hours between dosage. Treatment with Aerius tablets also improves sleep and daytime activity, is measured by interrupting sleep and daily activities.

    Aerius tablets are effective in reducing the burden of seasonal allergic rhinitis as shown by the total quality of life exploration related to rhinitis-congenitis. The biggest improvement is recorded as areas related to practical issues and daily activities are limited by symptoms.

    Dynamic pharmacokinetics

    can quantify the plasma concentration of desloratadine within 30 minutes using desloratadine. Desloratadine is well absorbed with the maximum concentration achieved after about 3 hours; Sales time of waste after about 27 hours.

    Desloratadine's accumulation level is suitable for the sale time of the drug (about 27 hours) and the dose once a day. The bioavailability of desloratadine is proportional to the dose of 5 mg to 20 mg.

    Desloratadine is moderately cohesive (83% - 87%) with plasma proteins. There is no evidence of clinical accumulation after daily dosage (5 mg to 20 mg) in 14 days.

  • Before taking Aerius 5mg Organon reduces allergic rhinitis, urticaria (1 blister x 10 tablets)

    How to use

    oral tablets. Take the tablet with a glass of water.

    Dosage

    Adults and adults (≥ 12 years old): A Aerius 5 mg film tablet, 1 time/day or non -meal, to reduce symptoms related to allergic rhinitis (including non -continuous allergic rhinitis and prolonged allergic rhinitis) and urticaria. Only oral use.

    Interrupted allergic rhinitis (symptoms that appear In prolonged allergic rhinitis (symptoms appear ≥ 4 days/week and last> 4 weeks), can be treated continuously during exposure to allergens.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

    do when overdose? Should treat symptoms and support treatment.

    On a multi -dose clinical study in adults and young people using desloratadine up to 45 mg (9 times higher than the clinical dose) did not observe the clinical manifestation of the overdose.

    Desloratadine is not excreted through hemolysis; It is unclear whether it is excreted through peritoneal.

    In case of emergency, call the 115 emergency center immediately or go to the nearest local health station.

    What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double doses to compensate for missed dose.

    Side Effects

    When using Aerius you may experience unwanted effects (ADR):

    In clinical trials in a variety of indications including allergic rhinitis and chronic urticaria, at the recommended dose of 5 mg/day, unwanted effects with Aerius have been reported in 3% of patients beyond the placebo -treated people. The most common unfavorable events reported in excess of the placebo are fatigue (1.2%), dry mouth (0.8%) and headache (0.6%).

    Group of children's patients

    In a clinical trial with 578 teenagers from 12 to 17 years old, the most common disadvantage is headache; This occurs in 5.9% of patients treated with desloratadine and 6.9% of placebo patients.

    List of adverse reactions

    The frequency of adverse reactions of the clinical trial is reported in excess of the placebo and other unwanted effects are reported in the after -sales stage listed in the following table.

    The frequency is defined: Very common (≥ 1/10), common (≥ 1/100 to Agency group system frequency

    Unknown

    illusion

    abnormal behavior, aggression

    Very rare

    Headache

    Dizziness, drowsiness, insomnia

    Increase mental activity - movement, seizures

    Unknown

    extends the range of qt

    Very rare

    dry mouth

    Abdominal pain, nausea, vomiting, indigestion, diarrhea, increased appetite

    Unknown

    Increase liver enzyme, increase bilirubin, hepatitis

    jaundice

    Skin disorders and subcutaneous skin disorders Drugs

    common

    Very rare

    Unknown

    tired

    Hypersensitivity reaction (such as anaphylaxis, angioedema, shortness of breath, itching, rash and urticaria).

    weakness

    Other undesirable effects are reported during after -sales period in children with unknown frequency including extending the QT, arrhythmia, slow heart rate, abnormal and aggressive behavior.

    Instructions on how to handle ADR:

    Notify the physician with unwanted effects when using the drug.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Aerius drug is contraindicated in the following cases:

  • Hypersensitivity to the active ingredient or any ingredient of the drug.
  • Be cautious when using

    need to be very careful when taking the drug for patients in the following cases:

    Not evaluating the safety and effectiveness of Aerius tablets in children under 12 years old.

    Desloratadin should be used carefully in patients with a history of a history or a family of epilepsy. In particular, children may be prone to epilepsy when treating with desloratadine. Health workers may consider stopping using desloratadine in patients with epilepsy during treatment.

    In case of severe renal failure, be careful when using Aerius.

    Patients with rare genetic problems in tolerance Galactose, Lapp Lactase deficiency or absorbent Glucose-Galactose should not use this drug.

    The effect of the drug on the ability to drive and operate machinery

    does not observe that it affects the ability to drive and operate machinery.

    Use drugs for women during pregnancy and lactation

    generally do not see the fertility in mice with desloratadine dose 34 times higher than the clinical dose proposed for humans.

    No observations of monitoring or gene mutations in animal tests using desloratadine. Because there is no clinical data on the use of desloratadine during pregnancy, Aerius' safety has not been determined during pregnancy. Do not use Aerius during pregnancy unless the benefits are out of risk.

    Do not use Aerius for breastfeeding women due to desloratadine to be secreted into breast milk.

    Drug interaction

    does not observe the clinical interaction with Aerius tablets in clinical trials.

    Food or grapefruit juice does not affect the allocation of desloratadine.

    Drinking Aerius with alcohol does not increase the risk of perceptions of alcoholism

    Storage

    Leave a cool place, avoid light, temperatures below 30⁰C.

    To be out of reach of children, read the instructions carefully before use.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords